Today, on 28 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2019 to Nasdaq Riga. Non-audited financial results indicate that the Group’s...
JSC Grindeks announces that the company’s Supervisory Council has approved Juris Hmelnickis as the Chairman of the Board. Kirovs Lipmans, Chairman of the Council of...
On Friday, January 17, Ambassador Extraordinary and Plenipotentiary of the Republic of Benin to Latvia, Eusebe Agbangla and Honorary Consul of the Republic of Benin,...
JSC Grindeks informs that the company has received a certification of Saudi Food and Drug Authority certifying the compliance of Grindeks final dosage forms –tablets...
On Tuesday, December 3, Ambassador Extraordinary and Plenipotentiary of Japan to Latvia Yasuhiro Kawaguchi and Attaché of Japanese Embassy in Latvia Kentaro Morimoto visited JSC...
Today, on November 28, JSC Grindeks submitted the non-audited consolidated financial statements of the first nine months of 2019 to Nasdaq Riga. Non-audited financial results...
On November 14 in Russia’s capital city Moscow the eighth pharmaceutical industry product competition “Russian Pharma Awards”® ceremony was held during which Grindeks product Viprosal...
